Edwards Lifesciences Corp. (EW) Tops Q4 EPS by 13c; Guides Q1, FY13
Tweet Send to a Friend
Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.90, $0.13 better than the analyst estimate of $0.77. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
